TBK1-stabilized ZNF268a recruits SETD4 to methylate TBK1 for efficient interferon signaling
Journal of Biological Chemistry · 2023-12 · 299 (12) · 105428
DOI: 10.1016/j.jbc.2023.105428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-12. Verfasst von Yi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, Hubei, P.R. China. Hauptthemen laut MEDLINE: Interferon Type I, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wuhan University, National Natural Science Foundation of China, Wuhan University School of Medicine.
Abstract (Originalsprache)
Sufficient activation of interferon signaling is critical for the host to fight against invading viruses, in which post-translational modifications have been demonstrated to play a pivotal role. Here, we demonstrate that the human KRAB-zinc finger protein ZNF268a is essential for virus-induced interferon signaling. We find that cytoplasmic ZNF268a is constantly degraded by lysosome and thus remains low expressed in resting cell cytoplasm. Upon viral infection, TBK1 interacts with cytosolic ZNF268a to catalyze the phosphorylation of Serine 178 of ZNF268a, which prevents the degradation of ZNF268a, resulting in the stabilization and accumulation of ZNF268a in the cytoplasm. Furthermore, we provide evidence that stabilized ZNF268a recruits the lysine methyltransferase SETD4 to TBK1 to induce the mono-methylation of TBK1 on lysine 607, which is critical for the assembly of the TBK1 signaling complex. Notably, ZNF268 S178 is conserved among higher primates but absent in rodents. Meanwhile, rodent TBK1 607th aa happens to be replaced by arginine, possibly indicating a species-specific role of ZNF268a in regulating TBK1 during evolution. These findings reveal novel functions of ZNF268a and SETD4 in regulating antiviral interferon signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, Hubei, P.R. China.
- Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, P.R. China.
- School of Ecology and Environment, Key Laboratory of Biodiversity and Environment on the Qinghai-Tibetan Plateau of Ministry of Education, Tibet University, Lhasa, Tibet, P.R. China.
- Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, P.R. China; Hubei Provincial Key Laboratory of Allergy and Immunology, Wuhan, Hubei, P.R. China.
- Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, Hubei, P.R. China; School of Ecology and Environment, Key Laboratory of Biodiversity and Environment on the Qinghai-Tibetan Pl…
Förderung
- Wuhan University
- National Natural Science Foundation of China
- Wuhan University School of Medicine
- Lowy Medical Research Institute
Zitieren
APA
Liu, Y., Yin, W., Zeng, X., Fan, J., Liu, C., Gao, M., Huang, Z., Sun, G., & Guo, M. (2023). TBK1-stabilized ZNF268a recruits SETD4 to methylate TBK1 for efficient interferon signaling. Journal of Biological Chemistry, 299(12), 105428. https://doi.org/10.1016/j.jbc.2023.105428
Vancouver
Liu Y, Yin W, Zeng X, Fan J, Liu C, Gao M, et al. TBK1-stabilized ZNF268a recruits SETD4 to methylate TBK1 for efficient interferon signaling. Journal of Biological Chemistry. 2023;299(12):105428. doi:10.1016/j.jbc.2023.105428
BibTeX
@article{Liu2023,
author = {Liu, Yi and Yin, Wei and Zeng, Xianhuang and Fan, Jinhao and Liu, Chaozhi and Gao, Mingyu and Huang, Zan and Sun, Guihong and Guo, Mingxiong},
title = {TBK1-stabilized ZNF268a recruits SETD4 to methylate TBK1 for efficient interferon signaling},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {12},
pages = {105428},
doi = {10.1016/j.jbc.2023.105428}
}
EUVIMED